Salidroside may improve lung function in mice with acute lung injury from CLP-induced sepsis by inhibiting caveolin-1 and TLR/NF-kappa B pathways in vivo inhibiting caveolin-1 and TLR/NF-kappa B pathways in vivo (Liu et al., 2017b). Here, CAV1 is linked to Sepsis.